Friday, 30 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Capacity Expansion

Shilpa Medicare Capacity Expansion

Shilpa Biologicals commissioned a cutting‑edge ADC GMP manufacturing facility. The plant expands Shilpa Medicare’s CDMO capabilities for oncology drug substances.

Source

BSE filing, NSE: SHILPAMED. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Shilpa Medicare Ltd: key numbers

Share price
₹955.60
Market cap
₹18,690 Cr
Revenue (annual)
₹1,539 Cr
Net profit (annual)
₹243.3 Cr
P/E (TTM)
62.9×Sector 48.7×
Promoter holding
40.13%+0.00% QoQ
FII holding
12.11%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Shilpa Medicare Ltd

All →

Other capacity expansion announcements

All →
19:51 IST BSE
Capacity ExpansionLotus Eye Hospital and Institute Ltd LOTUSEYE

Lotus Eye Hospital and Institute Capacity Expansion

Lotus Eye Hospital opened its 11th branch at Erode, Tamil Nadu, commencing operations on October 30, 2026. The branch was inaugurated with state government ministers and local MLAs in attendance.

new branches
1.0 branches